| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | yes | yes: 18 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 | 
| NetGPI | no | yes: 0, no: 11 | 
Related structures:
AlphaFold database: A4IBS1
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 170 | 172 | PF00675 | 0.344 | 
| CLV_NRD_NRD_1 | 197 | 199 | PF00675 | 0.552 | 
| CLV_PCSK_KEX2_1 | 170 | 172 | PF00082 | 0.344 | 
| CLV_PCSK_KEX2_1 | 197 | 199 | PF00082 | 0.497 | 
| CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.454 | 
| DOC_CYCLIN_RxL_1 | 99 | 106 | PF00134 | 0.479 | 
| DOC_MAPK_DCC_7 | 30 | 38 | PF00069 | 0.432 | 
| DOC_MAPK_FxFP_2 | 282 | 285 | PF00069 | 0.412 | 
| DOC_MAPK_gen_1 | 170 | 176 | PF00069 | 0.356 | 
| DOC_MAPK_gen_1 | 23 | 33 | PF00069 | 0.428 | 
| DOC_MAPK_MEF2A_6 | 91 | 99 | PF00069 | 0.278 | 
| DOC_PP1_RVXF_1 | 10 | 17 | PF00149 | 0.439 | 
| DOC_PP4_FxxP_1 | 282 | 285 | PF00568 | 0.420 | 
| DOC_USP7_MATH_1 | 285 | 289 | PF00917 | 0.460 | 
| DOC_USP7_MATH_1 | 292 | 296 | PF00917 | 0.595 | 
| DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.482 | 
| DOC_WW_Pin1_4 | 213 | 218 | PF00397 | 0.418 | 
| DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.425 | 
| LIG_14-3-3_CanoR_1 | 110 | 116 | PF00244 | 0.412 | 
| LIG_Actin_WH2_2 | 57 | 75 | PF00022 | 0.433 | 
| LIG_BRCT_BRCA1_1 | 92 | 96 | PF00533 | 0.359 | 
| LIG_FHA_1 | 16 | 22 | PF00498 | 0.399 | 
| LIG_FHA_1 | 177 | 183 | PF00498 | 0.547 | 
| LIG_FHA_1 | 39 | 45 | PF00498 | 0.399 | 
| LIG_FHA_1 | 56 | 62 | PF00498 | 0.384 | 
| LIG_FHA_1 | 99 | 105 | PF00498 | 0.421 | 
| LIG_FHA_2 | 112 | 118 | PF00498 | 0.411 | 
| LIG_LIR_Apic_2 | 142 | 146 | PF02991 | 0.493 | 
| LIG_LIR_Apic_2 | 279 | 285 | PF02991 | 0.490 | 
| LIG_LIR_Gen_1 | 114 | 123 | PF02991 | 0.409 | 
| LIG_LIR_Gen_1 | 18 | 27 | PF02991 | 0.409 | 
| LIG_LIR_Gen_1 | 46 | 57 | PF02991 | 0.396 | 
| LIG_LIR_Gen_1 | 93 | 100 | PF02991 | 0.359 | 
| LIG_LIR_Nem_3 | 114 | 118 | PF02991 | 0.387 | 
| LIG_LIR_Nem_3 | 159 | 165 | PF02991 | 0.299 | 
| LIG_LIR_Nem_3 | 279 | 284 | PF02991 | 0.461 | 
| LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.383 | 
| LIG_LIR_Nem_3 | 93 | 99 | PF02991 | 0.373 | 
| LIG_LYPXL_yS_3 | 284 | 287 | PF13949 | 0.483 | 
| LIG_PCNA_yPIPBox_3 | 197 | 207 | PF02747 | 0.504 | 
| LIG_PCNA_yPIPBox_3 | 5 | 17 | PF02747 | 0.569 | 
| LIG_Pex14_2 | 158 | 162 | PF04695 | 0.361 | 
| LIG_Pex14_2 | 278 | 282 | PF04695 | 0.394 | 
| LIG_SH2_GRB2like | 270 | 273 | PF00017 | 0.404 | 
| LIG_SH2_SRC | 115 | 118 | PF00017 | 0.384 | 
| LIG_SH2_STAT3 | 189 | 192 | PF00017 | 0.545 | 
| LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.384 | 
| LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.344 | 
| LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.557 | 
| LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.370 | 
| LIG_SH2_STAT5 | 270 | 273 | PF00017 | 0.404 | 
| LIG_SH3_3 | 117 | 123 | PF00018 | 0.485 | 
| LIG_SUMO_SIM_anti_2 | 114 | 120 | PF11976 | 0.401 | 
| LIG_SUMO_SIM_anti_2 | 48 | 54 | PF11976 | 0.374 | 
| LIG_SUMO_SIM_par_1 | 60 | 67 | PF11976 | 0.423 | 
| LIG_TRAF2_1 | 226 | 229 | PF00917 | 0.566 | 
| LIG_UBA3_1 | 230 | 239 | PF00899 | 0.470 | 
| MOD_CK1_1 | 288 | 294 | PF00069 | 0.539 | 
| MOD_CK1_1 | 60 | 66 | PF00069 | 0.411 | 
| MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.432 | 
| MOD_GlcNHglycan | 290 | 293 | PF01048 | 0.514 | 
| MOD_GlcNHglycan | 294 | 297 | PF01048 | 0.592 | 
| MOD_GlcNHglycan | 299 | 302 | PF01048 | 0.592 | 
| MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.560 | 
| MOD_GSK3_1 | 288 | 295 | PF00069 | 0.600 | 
| MOD_GSK3_1 | 297 | 304 | PF00069 | 0.683 | 
| MOD_N-GLC_1 | 285 | 290 | PF02516 | 0.460 | 
| MOD_PIKK_1 | 285 | 291 | PF00454 | 0.469 | 
| MOD_PIKK_1 | 55 | 61 | PF00454 | 0.465 | 
| MOD_PKA_2 | 90 | 96 | PF00069 | 0.471 | 
| MOD_Plk_1 | 285 | 291 | PF00069 | 0.518 | 
| MOD_Plk_4 | 111 | 117 | PF00069 | 0.479 | 
| MOD_Plk_4 | 57 | 63 | PF00069 | 0.385 | 
| MOD_Plk_4 | 90 | 96 | PF00069 | 0.392 | 
| MOD_ProDKin_1 | 213 | 219 | PF00069 | 0.418 | 
| MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.418 | 
| TRG_DiLeu_BaEn_2 | 244 | 250 | PF01217 | 0.497 | 
| TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.375 | 
| TRG_ENDOCYTIC_2 | 166 | 169 | PF00928 | 0.344 | 
| TRG_ENDOCYTIC_2 | 248 | 251 | PF00928 | 0.370 | 
| TRG_ENDOCYTIC_2 | 270 | 273 | PF00928 | 0.404 | 
| TRG_ENDOCYTIC_2 | 284 | 287 | PF00928 | 0.409 | 
| TRG_ER_diArg_1 | 169 | 171 | PF00400 | 0.334 | 
| TRG_NES_CRM1_1 | 42 | 56 | PF08389 | 0.480 | 
| TRG_Pf-PMV_PEXEL_1 | 255 | 259 | PF00026 | 0.471 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1I289 | Leptomonas seymouri | 79% | 100% | 
| A0A0S4J0X3 | Bodo saltans | 50% | 96% | 
| A0A1X0P6M3 | Trypanosomatidae | 66% | 100% | 
| A0A3R7KQI7 | Trypanosoma rangeli | 67% | 100% | 
| A0A3S7X9T6 | Leishmania donovani | 100% | 100% | 
| A4HN54 | Leishmania braziliensis | 83% | 100% | 
| C9ZYV1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 100% | 
| E9AFK7 | Leishmania major | 96% | 100% | 
| E9B6R1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% | 
| V5BXZ4 | Trypanosoma cruzi | 67% | 100% |